Ultra-fractionated radiation therapy for radiation injuries

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Oct 2022: Trial started, NCT05762900
  2. 10 Mar 2023: Trial registered, NCT05762900

The trials

NCT05762900: Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients

State
Under way
Phase
Phase 2
People
65 planned
Started
25 Oct 2022
Primary completion
25 Oct 2025
Arms
Ultra-hypofractionated arm
Results
None posted
  1. 25 Oct 2022: Trial started
  2. 10 Mar 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.